“Fact Checking” with the Patient Community: An Industry-Advocacy Collaboration for Optimizing Trial Design: This poster is ...

On September 12 th, Bright Minds Biosciences announced the initiation of the BREAKTHROUGH Study, an open-label Phase 2 clinical trial evaluating the safety, tolerability, and efficacy of BMB-101 in ...

This article is based on a poster originally authored by Nermeen Ali ... should not be considered validated by independent ...

Ipsen to present new data on elafibranor at The Liver Meeting® 2024Launch of Iqirvo® (elafibranor)1 on track with expectations; encouraging feedback from healthcare providers ...

On track to report topline data from Phase 2 TRANQUILITY trial in first half of 2025 – – Assembled Cardiovascular Scientific Advisory Board (CV SAB), comprised of leading academic and industry experts ...

Five BriaCell poster presentations to highlight updated survival and key biomarker data from Phase 2 trial of Bria-IMT™ plus immune check point inhibitor in metastatic breast cancer Presentations ...

Using analysis from an open-label, long-term treatment study of the RNS ® System, Rapport will present key new data on the correlation between the reduction in long episode (LE) frequency (abnormal ...

The team impressed judges with their research, showcasing their scientific prowess and commitment to tackling global health ...

Gift a Sex Wax air freshener. This product—for a car, house, or office—will take you back to sandy beaches, slow-rolling ...

"Code Green" is a sci-fi-inspired escape room with a heavy backstory and complex puzzles. It also resides in a dorm room at ...

Nektar Therapeutics Presents First Preclinical Data from Novel CSF-1 Program, NKTR-422, at 2024 American College of Rheumatology (ACR) Convergence ...

The day has finally come when we can enjoy the release of Stalker 2. Many years after the first announcement, GSC Game World ...